Testing effectiveness (Phase 2)Active Not RecruitingNCT02213926
What this trial is testing
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
Who this might be right for
Mantle Cell Lymphoma (MCL)
Acerta Pharma BV 124